Global Immunology Drug Market Insights, Forecast to 2031

Report ID: 1667131 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Immunology Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Immunology Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies (mAb)
        1.2.3 Antibody Drug Conjugates
        1.2.4 Immunosuppressive medication
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Immunology Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Cancer Research Centers and Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Immunology Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Immunology Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Immunology Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Immunology Drug Sales by Region
        2.4.1 Global Immunology Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Immunology Drug by Region (2023-2028)
    2.5 Global Immunology Drug Revenue by Region
        2.5.1 Global Immunology Drug Revenue by Region (2017-2022)
        2.5.2 Global Immunology Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Immunology Drug Sales by Manufacturers
        3.1.1 Global Top Immunology Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Immunology Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunology Drug in 2021
    3.2 Global Immunology Drug Revenue by Manufacturers
        3.2.1 Global Immunology Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Immunology Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Immunology Drug Revenue in 2021
    3.3 Global Immunology Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Immunology Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Immunology Drug Sales by Type
        4.1.1 Global Immunology Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Immunology Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Immunology Drug Sales Market Share by Type (2017-2028)
    4.2 Global Immunology Drug Revenue by Type
        4.2.1 Global Immunology Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Immunology Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Immunology Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Immunology Drug Price by Type
        4.3.1 Global Immunology Drug Price by Type (2017-2022)
        4.3.2 Global Immunology Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Immunology Drug Sales by Application
        5.1.1 Global Immunology Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Immunology Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Immunology Drug Sales Market Share by Application (2017-2028)
    5.2 Global Immunology Drug Revenue by Application
        5.2.1 Global Immunology Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Immunology Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Immunology Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Immunology Drug Price by Application
        5.3.1 Global Immunology Drug Price by Application (2017-2022)
        5.3.2 Global Immunology Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Immunology Drug Market Size by Type
        6.1.1 North America Immunology Drug Sales by Type (2017-2028)
        6.1.2 North America Immunology Drug Revenue by Type (2017-2028)
    6.2 North America Immunology Drug Market Size by Application
        6.2.1 North America Immunology Drug Sales by Application (2017-2028)
        6.2.2 North America Immunology Drug Revenue by Application (2017-2028)
    6.3 North America Immunology Drug Market Size by Country
        6.3.1 North America Immunology Drug Sales by Country (2017-2028)
        6.3.2 North America Immunology Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Immunology Drug Market Size by Type
        7.1.1 Europe Immunology Drug Sales by Type (2017-2028)
        7.1.2 Europe Immunology Drug Revenue by Type (2017-2028)
    7.2 Europe Immunology Drug Market Size by Application
        7.2.1 Europe Immunology Drug Sales by Application (2017-2028)
        7.2.2 Europe Immunology Drug Revenue by Application (2017-2028)
    7.3 Europe Immunology Drug Market Size by Country
        7.3.1 Europe Immunology Drug Sales by Country (2017-2028)
        7.3.2 Europe Immunology Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Immunology Drug Market Size by Type
        8.1.1 Asia Pacific Immunology Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Immunology Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Immunology Drug Market Size by Application
        8.2.1 Asia Pacific Immunology Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Immunology Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Immunology Drug Market Size by Region
        8.3.1 Asia Pacific Immunology Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Immunology Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Immunology Drug Market Size by Type
        9.1.1 Latin America Immunology Drug Sales by Type (2017-2028)
        9.1.2 Latin America Immunology Drug Revenue by Type (2017-2028)
    9.2 Latin America Immunology Drug Market Size by Application
        9.2.1 Latin America Immunology Drug Sales by Application (2017-2028)
        9.2.2 Latin America Immunology Drug Revenue by Application (2017-2028)
    9.3 Latin America Immunology Drug Market Size by Country
        9.3.1 Latin America Immunology Drug Sales by Country (2017-2028)
        9.3.2 Latin America Immunology Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Immunology Drug Market Size by Type
        10.1.1 Middle East and Africa Immunology Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Immunology Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Immunology Drug Market Size by Application
        10.2.1 Middle East and Africa Immunology Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Immunology Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Immunology Drug Market Size by Country
        10.3.1 Middle East and Africa Immunology Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Immunology Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Overview
        11.1.3 Abbott Laboratories Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Laboratories Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Active Biotech
        11.2.1 Active Biotech Corporation Information
        11.2.2 Active Biotech Overview
        11.2.3 Active Biotech Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Active Biotech Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Active Biotech Recent Developments
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Corporation Information
        11.3.2 Eli Lilly and Company Overview
        11.3.3 Eli Lilly and Company Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Eli Lilly and Company Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lilly and Company Recent Developments
    11.4 Autoimmune Inc.
        11.4.1 Autoimmune Inc. Corporation Information
        11.4.2 Autoimmune Inc. Overview
        11.4.3 Autoimmune Inc. Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Autoimmune Inc. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Autoimmune Inc. Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Corporation Information
        11.5.2 Pfizer Overview
        11.5.3 Pfizer Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Pfizer Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Pfizer Recent Developments
    11.6 GlaxoSmithKline plc
        11.6.1 GlaxoSmithKline plc Corporation Information
        11.6.2 GlaxoSmithKline plc Overview
        11.6.3 GlaxoSmithKline plc Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 GlaxoSmithKline plc Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 GlaxoSmithKline plc Recent Developments
    11.7 Seattle Genetics
        11.7.1 Seattle Genetics Corporation Information
        11.7.2 Seattle Genetics Overview
        11.7.3 Seattle Genetics Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Seattle Genetics Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Seattle Genetics Recent Developments
    11.8 Genentech
        11.8.1 Genentech Corporation Information
        11.8.2 Genentech Overview
        11.8.3 Genentech Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Genentech Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Genentech Recent Developments
    11.9 F. Hoffmann-La Roche Ltd.
        11.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
        11.9.2 F. Hoffmann-La Roche Ltd. Overview
        11.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
    11.10 Eisai Co.
        11.10.1 Eisai Co. Corporation Information
        11.10.2 Eisai Co. Overview
        11.10.3 Eisai Co. Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Eisai Co. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Eisai Co. Recent Developments
    11.11 Bayer AG
        11.11.1 Bayer AG Corporation Information
        11.11.2 Bayer AG Overview
        11.11.3 Bayer AG Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Bayer AG Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Bayer AG Recent Developments
    11.12 Sanofi Aventis LLC.
        11.12.1 Sanofi Aventis LLC. Corporation Information
        11.12.2 Sanofi Aventis LLC. Overview
        11.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Sanofi Aventis LLC. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Sanofi Aventis LLC. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Immunology Drug Industry Chain Analysis
    12.2 Immunology Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Immunology Drug Production Mode & Process
    12.4 Immunology Drug Sales and Marketing
        12.4.1 Immunology Drug Sales Channels
        12.4.2 Immunology Drug Distributors
    12.5 Immunology Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Immunology Drug Industry Trends
    13.2 Immunology Drug Market Drivers
    13.3 Immunology Drug Market Challenges
    13.4 Immunology Drug Market Restraints
14 Key Findings in The Global Immunology Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Immunology Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Monoclonal Antibodies (mAb)
    Table 3. Major Manufacturers of Antibody Drug Conjugates
    Table 4. Major Manufacturers of Immunosuppressive medication
    Table 5. Major Manufacturers of Others
    Table 6. Global Immunology Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Immunology Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Immunology Drug Sales by Region (2017-2022) & (MT)
    Table 9. Global Immunology Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Immunology Drug Sales by Region (2023-2028) & (MT)
    Table 11. Global Immunology Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Immunology Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Immunology Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Immunology Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Immunology Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Immunology Drug Sales by Manufacturers (2017-2022) & (MT)
    Table 17. Global Immunology Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Immunology Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Immunology Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Immunology Drug Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 21. Global Immunology Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Immunology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunology Drug as of 2021)
    Table 23. Immunology Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Immunology Drug Product Offered
    Table 25. Date of Manufacturers Enter into Immunology Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Immunology Drug Sales by Type (2017-2022) & (MT)
    Table 28. Global Immunology Drug Sales by Type (2023-2028) & (MT)
    Table 29. Global Immunology Drug Sales Share by Type (2017-2022)
    Table 30. Global Immunology Drug Sales Share by Type (2023-2028)
    Table 31. Global Immunology Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Immunology Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Immunology Drug Revenue Share by Type (2017-2022)
    Table 34. Global Immunology Drug Revenue Share by Type (2023-2028)
    Table 35. Immunology Drug Price by Type (2017-2022) & (USD/Kg)
    Table 36. Global Immunology Drug Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 37. Global Immunology Drug Sales by Application (2017-2022) & (MT)
    Table 38. Global Immunology Drug Sales by Application (2023-2028) & (MT)
    Table 39. Global Immunology Drug Sales Share by Application (2017-2022)
    Table 40. Global Immunology Drug Sales Share by Application (2023-2028)
    Table 41. Global Immunology Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Immunology Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Immunology Drug Revenue Share by Application (2017-2022)
    Table 44. Global Immunology Drug Revenue Share by Application (2023-2028)
    Table 45. Immunology Drug Price by Application (2017-2022) & (USD/Kg)
    Table 46. Global Immunology Drug Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 47. North America Immunology Drug Sales by Type (2017-2022) & (MT)
    Table 48. North America Immunology Drug Sales by Type (2023-2028) & (MT)
    Table 49. North America Immunology Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Immunology Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Immunology Drug Sales by Application (2017-2022) & (MT)
    Table 52. North America Immunology Drug Sales by Application (2023-2028) & (MT)
    Table 53. North America Immunology Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Immunology Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Immunology Drug Sales by Country (2017-2022) & (MT)
    Table 56. North America Immunology Drug Sales by Country (2023-2028) & (MT)
    Table 57. North America Immunology Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Immunology Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Immunology Drug Sales by Type (2017-2022) & (MT)
    Table 60. Europe Immunology Drug Sales by Type (2023-2028) & (MT)
    Table 61. Europe Immunology Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Immunology Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Immunology Drug Sales by Application (2017-2022) & (MT)
    Table 64. Europe Immunology Drug Sales by Application (2023-2028) & (MT)
    Table 65. Europe Immunology Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Immunology Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Immunology Drug Sales by Country (2017-2022) & (MT)
    Table 68. Europe Immunology Drug Sales by Country (2023-2028) & (MT)
    Table 69. Europe Immunology Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Immunology Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Immunology Drug Sales by Type (2017-2022) & (MT)
    Table 72. Asia Pacific Immunology Drug Sales by Type (2023-2028) & (MT)
    Table 73. Asia Pacific Immunology Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Immunology Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Immunology Drug Sales by Application (2017-2022) & (MT)
    Table 76. Asia Pacific Immunology Drug Sales by Application (2023-2028) & (MT)
    Table 77. Asia Pacific Immunology Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Immunology Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Immunology Drug Sales by Region (2017-2022) & (MT)
    Table 80. Asia Pacific Immunology Drug Sales by Region (2023-2028) & (MT)
    Table 81. Asia Pacific Immunology Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Immunology Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Immunology Drug Sales by Type (2017-2022) & (MT)
    Table 84. Latin America Immunology Drug Sales by Type (2023-2028) & (MT)
    Table 85. Latin America Immunology Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Immunology Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Immunology Drug Sales by Application (2017-2022) & (MT)
    Table 88. Latin America Immunology Drug Sales by Application (2023-2028) & (MT)
    Table 89. Latin America Immunology Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Immunology Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Immunology Drug Sales by Country (2017-2022) & (MT)
    Table 92. Latin America Immunology Drug Sales by Country (2023-2028) & (MT)
    Table 93. Latin America Immunology Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Immunology Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Immunology Drug Sales by Type (2017-2022) & (MT)
    Table 96. Middle East and Africa Immunology Drug Sales by Type (2023-2028) & (MT)
    Table 97. Middle East and Africa Immunology Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Immunology Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Immunology Drug Sales by Application (2017-2022) & (MT)
    Table 100. Middle East and Africa Immunology Drug Sales by Application (2023-2028) & (MT)
    Table 101. Middle East and Africa Immunology Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Immunology Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Immunology Drug Sales by Country (2017-2022) & (MT)
    Table 104. Middle East and Africa Immunology Drug Sales by Country (2023-2028) & (MT)
    Table 105. Middle East and Africa Immunology Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Immunology Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Abbott Laboratories Corporation Information
    Table 108. Abbott Laboratories Description and Major Businesses
    Table 109. Abbott Laboratories Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 110. Abbott Laboratories Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Abbott Laboratories Recent Developments
    Table 112. Active Biotech Corporation Information
    Table 113. Active Biotech Description and Major Businesses
    Table 114. Active Biotech Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 115. Active Biotech Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Active Biotech Recent Developments
    Table 117. Eli Lilly and Company Corporation Information
    Table 118. Eli Lilly and Company Description and Major Businesses
    Table 119. Eli Lilly and Company Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 120. Eli Lilly and Company Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Eli Lilly and Company Recent Developments
    Table 122. Autoimmune Inc. Corporation Information
    Table 123. Autoimmune Inc. Description and Major Businesses
    Table 124. Autoimmune Inc. Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 125. Autoimmune Inc. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Autoimmune Inc. Recent Developments
    Table 127. Pfizer Corporation Information
    Table 128. Pfizer Description and Major Businesses
    Table 129. Pfizer Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 130. Pfizer Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Pfizer Recent Developments
    Table 132. GlaxoSmithKline plc Corporation Information
    Table 133. GlaxoSmithKline plc Description and Major Businesses
    Table 134. GlaxoSmithKline plc Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 135. GlaxoSmithKline plc Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. GlaxoSmithKline plc Recent Developments
    Table 137. Seattle Genetics Corporation Information
    Table 138. Seattle Genetics Description and Major Businesses
    Table 139. Seattle Genetics Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 140. Seattle Genetics Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Seattle Genetics Recent Developments
    Table 142. Genentech Corporation Information
    Table 143. Genentech Description and Major Businesses
    Table 144. Genentech Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 145. Genentech Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Genentech Recent Developments
    Table 147. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 148. F. Hoffmann-La Roche Ltd. Description and Major Businesses
    Table 149. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 150. F. Hoffmann-La Roche Ltd. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 152. Eisai Co. Corporation Information
    Table 153. Eisai Co. Description and Major Businesses
    Table 154. Eisai Co. Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 155. Eisai Co. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Eisai Co. Recent Developments
    Table 157. Bayer AG Corporation Information
    Table 158. Bayer AG Description and Major Businesses
    Table 159. Bayer AG Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 160. Bayer AG Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Bayer AG Recent Developments
    Table 162. Sanofi Aventis LLC. Corporation Information
    Table 163. Sanofi Aventis LLC. Description and Major Businesses
    Table 164. Sanofi Aventis LLC. Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 165. Sanofi Aventis LLC. Immunology Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Sanofi Aventis LLC. Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Immunology Drug Distributors List
    Table 170. Immunology Drug Customers List
    Table 171. Immunology Drug Market Trends
    Table 172. Immunology Drug Market Drivers
    Table 173. Immunology Drug Market Challenges
    Table 174. Immunology Drug Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immunology Drug Product Picture
    Figure 3. Global Immunology Drug Market Share by Type in 2021 & 2028
    Figure 3. Monoclonal Antibodies (mAb) Product Picture
    Figure 4. Antibody Drug Conjugates Product Picture
    Figure 5. Immunosuppressive medication Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Immunology Drug Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Cancer Research Centers and Institutes
    Figure 11. Immunology Drug Report Years Considered
    Figure 12. Global Immunology Drug Sales 2017-2028 (MT)
    Figure 13. Global Immunology Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Immunology Drug Revenue 2017-2028 (US$ Million)
    Figure 15. Global Immunology Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Immunology Drug Sales Market Share by Region (2017-2022)
    Figure 17. Global Immunology Drug Sales Market Share by Region (2023-2028)
    Figure 18. North America Immunology Drug Sales YoY (2017-2028) & (MT)
    Figure 19. North America Immunology Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Immunology Drug Sales YoY (2017-2028) & (MT)
    Figure 21. Europe Immunology Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Immunology Drug Sales YoY (2017-2028) & (MT)
    Figure 23. Asia-Pacific Immunology Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Immunology Drug Sales YoY (2017-2028) & (MT)
    Figure 25. Latin America Immunology Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Immunology Drug Sales YoY (2017-2028) & (MT)
    Figure 27. Middle East & Africa Immunology Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Immunology Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Immunology Drug in the World: Market Share by Immunology Drug Revenue in 2021
    Figure 30. Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Immunology Drug Sales Market Share by Type (2017-2028)
    Figure 32. Global Immunology Drug Revenue Market Share by Type (2017-2028)
    Figure 33. Global Immunology Drug Sales Market Share by Application (2017-2028)
    Figure 34. Global Immunology Drug Revenue Market Share by Application (2017-2028)
    Figure 35. North America Immunology Drug Sales Market Share by Type (2017-2028)
    Figure 36. North America Immunology Drug Revenue Market Share by Type (2017-2028)
    Figure 37. North America Immunology Drug Sales Market Share by Application (2017-2028)
    Figure 38. North America Immunology Drug Revenue Market Share by Application (2017-2028)
    Figure 39. North America Immunology Drug Sales Share by Country (2017-2028)
    Figure 40. North America Immunology Drug Revenue Share by Country (2017-2028)
    Figure 41. U.S. Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Immunology Drug Sales Market Share by Type (2017-2028)
    Figure 44. Europe Immunology Drug Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Immunology Drug Sales Market Share by Application (2017-2028)
    Figure 46. Europe Immunology Drug Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Immunology Drug Sales Share by Country (2017-2028)
    Figure 48. Europe Immunology Drug Revenue Share by Country (2017-2028)
    Figure 49. Germany Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. France Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Immunology Drug Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Immunology Drug Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Immunology Drug Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Immunology Drug Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Immunology Drug Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Immunology Drug Revenue Share by Region (2017-2028)
    Figure 60. China Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. India Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Immunology Drug Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Immunology Drug Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Immunology Drug Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Immunology Drug Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Immunology Drug Sales Share by Country (2017-2028)
    Figure 75. Latin America Immunology Drug Revenue Share by Country (2017-2028)
    Figure 76. Mexico Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Immunology Drug Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Immunology Drug Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Immunology Drug Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Immunology Drug Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Immunology Drug Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Immunology Drug Revenue Share by Country (2017-2028)
    Figure 85. Turkey Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Immunology Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. Immunology Drug Value Chain
    Figure 89. Immunology Drug Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Frequently Asked Questions
Immunology Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunology Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunology Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports